Revance Therapeutics
RVNC
$3.32
Share price
-22.61%
Change (1 day)
-90.71%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.16 B
According to Revance Therapeutics's latest financial reports the company has -$0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Revance Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.16 B | -1303.21% |
| 2022-12-31 | $12.6 M | -81.6% |
| 2021-12-31 | $68.47 M | -81.71% |
| 2020-12-31 | $0.37 B | 65.99% |
| 2019-12-31 | $0.22 B | 54.85% |
| 2018-12-31 | $0.14 B | -45.83% |
| 2017-12-31 | $0.26 B | 51.83% |
| 2016-12-31 | $0.17 B | -30.08% |
| 2015-12-31 | $0.25 B | 43.59% |
| 2014-12-31 | $0.17 B | -211.95% |
| 2013-12-31 | $-0.16 B | -27.31% |
| 2012-12-31 | $-0.22 B | 39.39% |
| 2011-12-31 | $-0.16 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | -46,286.12% | 🇺🇸 USA |
 Biogen BIIB | $15.21 B | -10,134.70% | 🇺🇸 USA |
 MediciNova MNOV | $62.37 M | -141.15% | 🇺🇸 USA |